Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-26 @ 2:59 AM
Study NCT ID:
NCT00089102
Status:
TERMINATED
Last Update Posted:
2018-07-16
First Post:
2004-08-04
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer
Sponsor:
Medical University of South Carolina
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000378044
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None